Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CARM1 | Q86X55 | 1/20 | 0.41 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.41 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.41 |
| ▸ | PRMT8 | Q9NR22 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 3/20 | 0.36 |
| ▸ | HRH3 | Q9Y5N1 | 6/20 | 0.35 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12449708 | 1.00 | CARM1 (0.41) | CARM1PRMT6PRMT1PRMT8ACHE | |
| SCHEMBL12449704 | 1.00 | CARM1 (0.41) | CARM1PRMT6PRMT1PRMT8ACHE | |
| SCHEMBL12449687 | 0.91 | CARM1 (0.45) | CARM1PRMT6PRMT1PRMT8ACHE | |
| SCHEMBL12451 | 0.91 | CARM1 (0.45) | CARM1PRMT6PRMT1PRMT8ACHE | |
| SCHEMBL12449652 | 0.90 | KDM4E (0.45) | HRH3POLBKDM4E | |
| SCHEMBL12449651 | 0.90 | KDM4E (0.45) | HRH3POLBKDM4E | |
| SCHEMBL12774 | 0.90 | KDM4E (0.45) | HRH3POLBKDM4E | |
| SCHEMBL12775 | 0.90 | KDM4E (0.45) | HRH3POLBKDM4E | |
| SCHEMBL12522637 | 0.88 | KDM4E (0.37) | CARM1PRMT6PRMT1PRMT8HRH3 | |
| SCHEMBL12449657 | 0.82 | KDM4E (0.45) | HRH3POLBKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011058149-A1 | TRICYCLIC PYRAZOL AMINE DERIVATIVES | MERCK SERONO S.A. (CH) | 2011-05-19 | — | — | WO | disclosed |